Biomedical engineering seeks to enhance the quality of life by developing advanced materials and technologies. Chitosan-based biomaterials have attracted significant attention because of having unique chemical structures with desired biocompatibility and biodegradability, which play different roles in membranes, sponges and scaffolds, along with bring about promising biological properties such as biocompatibility, biodegradability and non-toxicity. Therefore, chitosan derivatives have been widely used in a vast variety of uses, chiefly pharmaceuticals and biomedical engineering. It is attempted here to draw a comprehensive overview of chitosan emerging applications in medicine, tissue engineering, drug delivery, gene therapy, cancer therapy, ophthalmology, dentistry, bio-imaging, bio-sensing and diagnosis. The use of stem cells (SCs) has given an interesting feature to the use of chitosan, so that regenerative medicine and therapeutic methods have benefited from chitosan-based platforms. Plenty of the most recent discussions with stimulating ideas in this field are covered that could hopefully serve as hints for more developed works in biomedical engineering.

No abstract

No abstract

New emerging technologies, remarkably miniaturized 3D organ models and microfluidics, enable simulation of the real in vitro microenvironment ex vivo more closely. There are many fascinating features of innovative organ‐on‐a‐chip (OOC) technology, including the possibility of integrating semipermeable and/or stretchable membranes, creating continuous perfusion of fluids into microchannels and chambers (while maintaining laminar flow regime), embedding microdevices like microsensors, microstimulators, micro heaters, or different cell lines, along with other 3D cell culture technologies. OOC systems are designed to imitate the structure and function of human organs, ranging from breathing lungs to beating hearts. This technology is expected to be able to revolutionize cell biology studies, personalized precision medicine, drug development process, and cancer diagnosis/treatment. OOC systems can significantly reduce the cost associated with tedious drug development processes and the risk of adverse drug reactions in the body, which makes drug screening more effective. The review mainly focus on presenting an overview of the several previously developed OOC systems accompanied by subjects relevant to pharmacy‐, cancer‐, and placenta‐on‐a‐chip. The challenging issues and opportunities related to these systems are discussed, along with a future perspective for this technology.

A green adsorbent was evaluated to remove the carmine dye. Chitin nanowhiskers were synthesized via acid hydrolyzed method. The diameter of the synthesized chitin whiskers was about 20 nm and had 200 to 400 nm length. The morphology and chemical structure of the synthesized adsorbent were investigated by Field Emission Scanning Electron Microscopy (FESEM), Transmission Electron Microscopy (TEM), Fourier Transform Infrared (FT-IR), X- Ray Diffraction (XRD). The adsorption process parameters of the carmine dye removal were optimized as follow: adsorption time (3 h), initial carmine dye solution concentration (100 ppm), mass loaded of the chitin whiskers suspension 1% weight of chitin nanowhiskers, as an adsorbent (1.4 g). The removal efficiency of the carmine dye adsorption was about 85% which is modified 15% better than the previous researches. The results indicated that carmine dye molecules were absorbed by hydrogen bonding mechanism due to the N-H bond in the chitin nanowhiskers structure.